Gene · 51755
Papers3,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction for Sun et al., DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers. | Proc Natl Acad Sci U S A | 2025 | 40875816 | PubTator, text mining | PubMed |
| DNA methylation and transcription factor-driven immune subtypes in ovarian cancer. | Discov Oncol | 2025 | 40875153 | PubTator, text mining | PubMed |
| Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study. | Nat Commun | 2025 | 40858617 | PubTator, text mining | PubMed |
| The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategies. | Med Oncol | 2025 | 40856900 | PubTator, text mining | PubMed |
| Soluble PD-L1 (sPD-L1) as a biomarker of durable response and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with first-line immune checkpoint inhibitors (ICIs). | Cancer Immunol Immunother | 2025 | 40856795 | PubTator, text mining | PubMed |
| The cAMP-PKA signaling initiates mitosis by phosphorylating Bora. | Nat Commun | 2025 | 40849432 | PubTator, text mining | PubMed |
| The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies. | Cancer Cytopathol | 2025 | 40847760 | PubTator, text mining | PubMed |
| Centromere protection requires strict mitotic inactivation of the Bloom syndrome helicase complex. | Nat Commun | 2025 | 40846865 | PubTator, text mining | PubMed |
| Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics. | Nat Commun | 2025 | 40835825 | PubTator, text mining | PubMed |
| Cooperative Free Energy: Induced Protein-Protein Interactions and Cooperative Solvation in Ternary Complexes. | J Chem Theory Comput | 2025 | 40832906 | PubTator, text mining | PubMed |
| The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers. | Biomark Res | 2025 | 40830526 | PubTator, text mining | PubMed |
| Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study. | JCO Precis Oncol | 2025 | 40825169 | PubTator, text mining | PubMed |
| Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance. | J Ovarian Res | 2025 | 40813689 | PubTator, text mining | PubMed |
| From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis. | Med Oncol | 2025 | 40782258 | PubTator, text mining | PubMed |
| Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations. | JCO Precis Oncol | 2025 | 40773712 | PubTator, text mining | PubMed |
| Mechanism of Astragaloside-Brucea javanica oil nanoemulsion against oral squamous cell carcinoma through CDK1/MTFR2: Network pharmacology, bioinformatics, and experimental studies. | PLoS One | 2025 | 40748969 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| High-Grade Early-Onset Prostate Cancer: Assessment of TMPRSS2::ERG -Negative Tumors Suggests Low Frequency of Germline Alterations and a Pathogenic Role for HOXB13. | Am J Surg Pathol | 2025 | 40745946 | PubTator, text mining | PubMed |
| Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data. | J Immunother Cancer | 2025 | 40744664 | PubTator, text mining | PubMed |
| Predicting pathogenic DNA damage repair gene mutations in prostate cancer patients: a multi-center magnetic resonance imaging radiomics study. | Quant Imaging Med Surg | 2025 | 40727372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51755/papers?page=9